Rather, Frieden said, this is evidence that drug manufacturers and regulators maintain a commitment to rigorous scientific principles that govern testing, even as they accelerate development timelines during the Kovid-19 pandemic Let’s look for.
Frieden, who led the CDC under the CDC since 2009, said, “It’s contradictory, but it’s really reassuring, because we expect to see signs that may not be indicative of the problem and we companies Hopes to stop. Obama administration. “It assures that we are not cutting corners on security.”
Frieden’s comments Tuesday on “Closing Bell” came after news that a late stage trial of Eli Lilly’s antibody treatment for Kovid-19 was being withheld by US regulators to evaluate a potential safety concern.
Just a day earlier, Johnson & Johnson confirmed that large-scale coronavirus vaccine testing was being halted as the Safety Monitoring Board investigated an “adverse event” in one participant. It is not yet known whether the person received the vaccine or the placebo.
The vaccine trial of British pharmaceutical company AstraZeneca continues in the US after an unexplained illness was reported in a United Kingdom participant. However, regulators in the UK and other countries have allowed the trials to resume.
Medical experts say that trial poses are not uncommon in the development of vaccines and drugs, which usually take years to complete. But the recent security standoff has attracted the attention of people due to an epidemic in the world that has killed more than 1 million people and devastated economies.
In the US, in particular, there has also been increased concern that the Coronovirus vaccine may be approved by the Trump administration for political reasons. Head of the Department of Food and Drug Administration, Dr. Stephen Hahn has sought to acknowledge those concerns, stating that he has no intention of career scientists at the agency.
Frieden acknowledged faith concerns about the vaccine, but the former New York City health commissioner stressed the need for the public to wait for more information before reaching a conclusion. “People say, ‘Will you take the vaccine?” If you asked me, I’d say, ‘It depends what the data represents.’ “As time progresses, we will learn more.”